|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00001599 |
|
Date of registration:
|
03/11/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Pilot Study of Thalidomide to Treat Sjogren's Syndrome
|
|
Scientific title:
|
Pilot Study of Thalidomide for Sjogren's Syndrome |
|
Date of first enrolment:
|
May 1997 |
|
Target sample size:
|
28 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00001599 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Primary Sjogren's Syndrome; symptoms of dry eyes and dry mouth; 6 week period off disease
modifying agents, such as antimalarials or steroids.
No males.
No females with childbearing potential.
No patients with hypersensitivity to thalidomide.
No confounding medical illness or abnormal laboratory test that in the judgment of the
investigators would pose added risk for study participants.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Xerostomia
|
|
Sjogren's Syndrome
|
|
Intervention(s)
|
|
Drug: Thalidomide
|
|
Secondary ID(s)
|
|
97-D-0133
|
|
970133
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|